Bedrijfsoverzicht
Universal Health Realty Income Trust is a real estate investment trust focused on acquiring and managing healthcare and human-service related facilities, which include acute care hospitals, behavioral health care hospitals, specialty facilities, medical and office buildings, free-standing emergency departments, and childcare centers. The company operates within the Real Estate sector, specifically in the REIT - Healthcare Facilities industry, positioning it to generate income through rental payments from essential service providers rather than direct patient care services. Its current market capitalization stands at $596.47M, supported by an annual revenue figure of $100.89M, while specific employee count data is not disclosed in the available records. These valuation and revenue metrics indicate that UHT functions as a mid-sized entity within the specialized healthcare infrastructure space, balancing asset scale with a niche operational focus that serves critical community health needs.
Financiële gezondheid
The company reports a Trailing Twelve Months revenue of $100.89M, generating a net income of $17.61M and an EBITDA of $66.05M, a significant gap between revenue and net income that reveals a high operating cost structure typical of asset-heavy real estate investments where depreciation and interest expenses substantially reduce bottom-line profits. The free cash flow stands at $45.65M, providing a substantial liquidity buffer that indicates strong financial flexibility to service debt obligations or pursue strategic capital allocation initiatives without relying on external financing. Margin analysis shows a gross margin of 94.5%, reflecting the high quality of rental income before operating costs, an operating margin of 39.6% demonstrating efficient management of facility-level expenses, and a profit margin of 17.5% that captures the final return after all obligations including debt servicing. On the balance sheet, the company holds $8.29M in cash against a total debt load of $386.03M, resulting in a debt-to-equity ratio of 253.33, which characterizes a highly leveraged balance sheet common in the REIT sector but requiring careful monitoring of refinancing risks. The current ratio is reported at 7.80, indicating an exceptionally strong short-term liquidity position where current assets far exceed current liabilities, ensuring the ability to meet immediate financial obligations. Return on Equity is 10.6% and Return on Assets is 4.1%, metrics that reveal management's effectiveness in generating returns on shareholder capital relative to the total asset base, with the lower ROA reflecting the impact of significant interest expenses on overall asset profitability.
Waarderingsbeoordeling
The trailing P/E ratio is 33.85, while the forward P/E is not available, a data gap that implies analysts cannot yet project a specific earnings trajectory or confirm whether current earnings are expected to expand or contract in the coming fiscal periods. The price-to-book ratio sits at 3.91, suggesting that the market values the company's equity at nearly four times its book value, which indicates a significant market premium likely driven by the stable cash flows inherent in healthcare real estate assets. Alternative valuation metrics show a price-to-sales ratio of 5.91 and an EV/EBITDA of 14.75, figures that suggest the market is willing to pay a premium for revenue and earnings power despite the lack of forward guidance. The stock has traded between a 52-week low of $35.26 and a 52-week high of $44.70, placing the current trading range within a historical band that reflects recent market volatility and sentiment adjustments around the asset class. With a beta of 0.89, the stock exhibits price volatility that is slightly lower than the broader market average, indicating a relative defensive characteristic often associated with essential service infrastructure investments.
Growth & Income
Revenue growth year-over-year is 0.0%, while earnings growth year-over-year is -8.1%, a dynamic where earnings are contracting faster than revenue or revenue is stagnant, implying that cost pressures or one-time adjustments are negatively impacting profitability despite stable top-line income. As a dividend payer, the company offers a dividend yield of 6.9% with a payout ratio of 233.1%, a high ratio that suggests dividends are currently funded largely by cash flow rather than retained earnings, potentially limiting the capacity for significant dividend increases without external capital raising. The earnings contraction relative to stagnant revenue highlights a period of financial consolidation or operational adjustments rather than organic expansion. Overall, the growth and income profile reflects a mature, income-focused asset with limited revenue expansion and a high yield that carries inherent sustainability risks given the elevated payout ratio relative to reported net income.